Item Second Irr. Trust FBO Kyle R. Westphal, a holder representing a ten percent ownership stake in Vertex, Inc. (NASDAQ: VERX), executed an open-market sale of 10,000 Class A Common Stock shares on March 9, 2026. The shares were sold across multiple transactions at prices that ranged from $15.02 to $15.06, producing a weighted average sale price of $15.0477 and a combined transaction value of $150,477.
Following this series of sales, the trust continues to directly hold 1,221,100 shares of Vertex, Inc. The sale coincides with a market price of $14.94 for VERX shares, and the stock has declined 54% over the last 12 months.
Market research available through InvestingPro is cited as classifying Vertex as appearing undervalued at current levels, with the shares included on the platform's Most Undervalued list. InvestingPro also offers a Pro Research Report for VERX and more than 1,400 other U.S. equities for investors seeking expanded valuation and performance metrics.
Vertex reported fourth-quarter 2025 results that were described as largely in line with consensus expectations. The earnings release triggered a variety of reactions from sell-side analysts, with several firms adjusting price targets and, in some cases, ratings.
DA Davidson cut its price target for Vertex from $23 to $13 but kept a Neutral rating. Jefferies downgraded the stock from Buy to Hold, citing weak key performance indicators and a transition in the company's chief executive officer, and lowered its target from $28 to $16. Needham reduced its price target to $20 from $30 while maintaining a Buy rating; Needham's adjustment followed Vertex's acknowledgement of revenue headwinds during the quarter, including the effects of bankruptcy and mergers. Goldman Sachs continued to carry a Buy rating and kept a $23 price target, emphasizing Vertex's focus on global compliance and e-invoicing opportunities. Citizens trimmed its target from $37 to $25 while maintaining a Market Outperform rating, citing concerns about the pace of product innovation.
Taken together, the analyst moves represent a mixed reception to Vertex's recent results and near-term outlook. Price targets now span from a low of $13 to a high of $25 among the named firms, with one outlier remaining at $23 from Goldman Sachs, underscoring divergent views on the company's trajectory following its fourth-quarter 2025 disclosure.
Investors tracking insider activity, valuation signals, and analyst commentary will likely view the trust's sale and the subsequent range of analyst responses as data points to weigh alongside the company's reported results. The trust's remaining direct stake of 1,221,100 shares preserves meaningful ownership, even after the dispersed sale executed at mid-March prices.